Sysmex Corporation (SSMXF)

Market Cap	6.19B -46.5%
Revenue (ttm)	3.37B +1.5%
Net Income	315.47M -12.7%
EPS	0.51 -12.6%
Shares Out	n/a
PE Ratio	19.63
Forward PE	n/a
Dividend	0.25 (2.55%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Average Volume	10,733
Open	9.88
Previous Close	9.88
Day's Range	9.88 - 9.88
52-Week Range	9.33 - 20.40
Beta	0.66
RSI	33.14
Earnings Date	Feb 12, 2026

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte co...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1968
• Employees: 10,533
• Stock Exchange: OTCMKTS
• Ticker Symbol: SSMXF

Financial Performance

In fiscal year 2025, Sysmex's revenue was 508.64 billion, an increase of 10.21% compared to the previous year's 461.51 billion. Earnings were 53.67 billion, an increase of 8.12%.

Financial numbers in JPY